Medical research

Resveratrol, quercetin could provide new options for cancer therapy

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential ...

Oncology & Cancer

Step closer to predicting cancer patients' drug toxicity

Being able to predict that a patient will adversely react to a drug that's meant to be treating them is a key aim of personalised medicine, and could help to improve the patient's overall treatment.

Medications

Zydelig approved for three types of blood cancer

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Oncology & Cancer

Cancer avatars for personalized medicine

Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated ...

Oncology & Cancer

Experimental drug may boost leukemia survival, without chemo

(HealthDay)—An experimental drug may extend the lives of people with certain hard-to-treat forms of leukemia and lymphoma—without the need for traditional chemotherapy, according to two studies released Wednesday.

page 8 from 16